Thomas Wakim Profile - Bell Potter Analyst
4 Followers
Thomas Wakim's Stock Coverage
| NEUNeuren Pharmaceuticals Limited | Nov 05, 2026 | BUY | Reiterated | AU$26.50 | 18Ratings | +17.92% | ||
| ATXAmplia Therapeutics | Nov 03, 2026 | BUY | Reiterated | AU$0.42 | 4Ratings | -20.90% | ||
| ALCAlcidion Group Limited | Nov 02, 2026 | BUY | Reiterated | AU$0.15 | 17Ratings | +16.19% | ||
| CGSCogstate Ltd | Oct 19, 2026 | BUY | Reiterated | AU$4.05 | 8Ratings | +30.80% | ||
| PYCPYC Therapeutics Limited | Oct 07, 2026 | BUY | Reiterated | AU$3.30 | 10Ratings | +15.79% | ||
| IMMImmutep Ltd | Sep 14, 2026 | HOLD | Reiterated | AU$0.06 | 9Ratings | -50.49% | ||
| CUVClinuvel Pharmaceuticals | Aug 27, 2026 | HOLD | Downgraded | AU$11.50 | 6Ratings | -1.42% | ||
| CSLCSL | Aug 19, 2026 | HOLD | Reiterated | AU$150.00 | 11Ratings | -10.95% | ||
| SNTSyntara Limited | Jul 28, 2026 | BUY | Reiterated | AU$0.06 | 7Ratings | -31.63% | ||
| MAPMicroba Life Sciences Limited | Jul 16, 2026 | HOLD | Downgraded | AU$0.05 | 13Ratings | -48.28% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Thomas Wakim activity FAQ
What is the performance of Thomas Wakim's recommendations?
The percentage of profitable recommendations made by Thomas Wakim is 47.13%, and the average return per transaction is -8.00%.
What stocks does Thomas Wakim cover?
Thomas Wakim mostly covers Neuren Pharmaceuticals Limited, Amplia Therapeutics, Alcidion Group Limited stocks.
What was Thomas Wakim's most profitable rating?
Thomas Wakim’s most profitable rating was a buy on PYC Therapeutics Limited stock on Sep 08, 2025. The return on the trade was 103.20%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here